Robotic Rehabilitation and Assistive Technologies Market Trends

  • Report ID: 4581
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Robotic Rehabilitation And Assistive Technologies Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Incidence of Orthopedic Illnesses - For instance, 58.5 million adults in the U.S. (23.7%), or 1 in 4, suffer from arthritis according to statistics from the Centers for Disease Control and Prevention (CDC).

  • Orthopedic diseases include bursitis, osteoarthritis, rheumatoid arthritis, cubital tunnel syndrome, elbow pain, elbow problems, and others. These diseases can affect the musculoskeletal system, such as, nerves, bones, joints, muscles, ligaments tendons, and others, and can cause severe physical disabilities. Robotic rehabilitation and assistive technologies are helpful to provide gait rehabilitation systems and other functions of the body.
  • Rising Geriatric Population - Elderly population is more prone to developing physical disabilities, and commonly, people above 70 to 90 find it difficult to move on their own. Hence, robotic rehabilitation and assistive technologies become beneficial to facilitate desired body movement. The percentage of individuals over 60 in the world will nearly double from 12 to 22% between 2015 and 2050. Additionally, it is projected that 80% of the world's old people will live in low- and middle-income countries.

  • Increasing Health Spending - A considerable amount of health spending is observed to be spent on the development of advanced medical equipment to provide better healthcare services. In 2019, global health spending reached around USD 8 trillion, summing up to 10% of the GDP which was estimated to be an increase from 8% in 2000.

  • Growing Number of Long-Term Care Facilities for the Geriatric - As of 2019, nearly 65,000 regulated long-term care facilities were noticed to function in the United States, providing services for approximately 8 million residents.

  • Surge in the Instances of Cardiovascular Diseases (CVDs) - For instance, with around 18 million fatalities per year (32.5% of all deaths), CVDs are the leading cause of death worldwide.

Challenges

  • Lack of Availability and Awareness About Rehabilitation Treatments in Developing Countries – Reasons, such as lack of awareness regarding the advantages of robotic rehabilitation for the disabled, lack of affordability as of low income, along with the poor healthcare infrastructure, are some of the factors which are estimated to negatively influencing the growth of the global robotic rehabilitation and assistive technologies market in emerging nations over the forecast period.

  • Concerns Associated with the Reimbursement

  • Lack of Trained Professionals


Base Year

2024

Forecast Year

2025-2037

CAGR

13.7%

Base Year Market Size (2024)

USD 2.59 billion

Forecast Year Market Size (2037)

USD 13.75 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of robotic rehabilitation and assistive technologies is evaluated at USD 3.19 billion.

The robotic rehabilitation and assistive technologies market size was valued at USD 2.59 billion in 2024 and is set to exceed USD 13.75 billion by 2037, expanding at over 13.7% CAGR during the forecast period i.e., between 2025-2037. Increasing incidence of orthopedic illnesses will drive the market growth.

North America industry is expected to dominate majority revenue share of 37% by 2037, attributed to rising chronic disease prevalence coupled escalating geriatric population, and a strong healthcare industry.

The major players in the market are AlterG, Inc., Bionik Laboratories Corp., Ekso Bionics Holdings, Inc., Vincent Medical Holdings Limited, Hocoma AG, CYBERDYNE Inc., Kinova inc., Rex Bionics Ltd, Instead Technologies Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos